Sungji Ha Selected Research

3,16-dihydroxyandrost-5-ene-17,19-dione

1/2018	Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model.
1/2016	Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sungji Ha Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2014
2	Amyloid Plaque 01/2018 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 05/2014
1	Neurodevelopmental Disorders 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Autism Spectrum Disorder 01/2021
1	Memory Disorders (Memory Loss) 01/2018
1	Autistic Disorder (Autism) 01/2017
1	Neoplasms (Cancer) 01/2014
1	Ischemia 03/2011

Drug/Important Bio-Agent (IBA)

3	Therapeutic UsesIBA 01/2018 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2011
2	3,16-dihydroxyandrost-5-ene-17,19-dioneIBA 01/2018 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2014
1	Biological ProductsIBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2021
1	dehydroevodiamineIBA 01/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Amyloid beta-PeptidesIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 01/2014

Therapy/Procedure

2	Therapeutics 01/2022 - 05/2014